183 related articles for article (PubMed ID: 32513143)
1. Personalising screening of sight-threatening diabetic retinopathy - qualitative evidence to inform effective implementation.
Byrne P; Thetford C; Gabbay M; Clarke P; Doncaster E; Harding SP;
BMC Public Health; 2020 Jun; 20(1):881. PubMed ID: 32513143
[TBL] [Abstract][Full Text] [Related]
2. Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.
Broadbent DM; Sampson CJ; Wang A; Howard L; Williams AE; Howlin SU; Appelbe D; Moitt T; Cheyne CP; Rahni MM; Kelly J; Collins J; García-Fiñana M; Stratton IM; James M; Harding SP;
BMJ Open; 2019 Jun; 9(6):e025788. PubMed ID: 31213445
[TBL] [Abstract][Full Text] [Related]
3. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.
Younis N; Broadbent DM; Harding SP; Vora JP
Diabet Med; 2003 Sep; 20(9):758-65. PubMed ID: 12925058
[TBL] [Abstract][Full Text] [Related]
4. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
Broadbent DM; Wang A; Cheyne CP; James M; Lathe J; Stratton IM; Roberts J; Moitt T; Vora JP; Gabbay M; García-Fiñana M; Harding SP;
Diabetologia; 2021 Jan; 64(1):56-69. PubMed ID: 33146763
[TBL] [Abstract][Full Text] [Related]
5. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme.
Misra A; Bachmann MO; Greenwood RH; Jenkins C; Shaw A; Barakat O; Flatman M; Jones CD
Diabet Med; 2009 Oct; 26(10):1040-7. PubMed ID: 19900237
[TBL] [Abstract][Full Text] [Related]
6. Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.
Cheyne CP; Burgess PI; Broadbent DM; García-Fiñana M; Stratton IM; Criddle T; Wang A; Alshukri A; Rahni MM; Vazquez-Arango P; Vora JP; Harding SP;
Diabet Med; 2021 Sep; 38(9):e14583. PubMed ID: 33830513
[TBL] [Abstract][Full Text] [Related]
7. Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort.
Lawrenson JG; Bourmpaki E; Bunce C; Stratton IM; Gardner P; Anderson J;
Diabet Med; 2021 Apr; 38(4):e14425. PubMed ID: 33064854
[TBL] [Abstract][Full Text] [Related]
8. Social determinants of diabetic retinopathy and impact of sight-threatening diabetic retinopathy: A study from Pune, India.
Kulkarni S; Patil V; Kashikar R; Deshpande R; Dole K
Indian J Ophthalmol; 2023 Feb; 71(2):358-362. PubMed ID: 36727320
[TBL] [Abstract][Full Text] [Related]
9. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.
Younis N; Broadbent DM; Vora JP; Harding SP;
Lancet; 2003 Jan; 361(9353):195-200. PubMed ID: 12547541
[TBL] [Abstract][Full Text] [Related]
10. Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study.
Lindenmeyer A; Sturt JA; Hipwell A; Stratton IM; Al-Athamneh N; Gadsby R; O'Hare JP; Scanlon PH
Br J Gen Pract; 2014 Aug; 64(625):e484-92. PubMed ID: 25071061
[TBL] [Abstract][Full Text] [Related]
11. Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study.
Olvera-Barrios A; Owen CG; Anderson J; Warwick AN; Chambers R; Bolter L; Wu Y; Welikala R; Fajtl J; Barman SA; Remagnino P; Chew EY; Ferris FL; Hingorani AD; Sofat R; Lee AY; Egan C; Tufail A; Rudnicka AR;
BMJ Open Diabetes Res Care; 2023 Nov; 11(6):. PubMed ID: 37949472
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme.
Ling R; Ramsewak V; Taylor D; Jacob J
Eye (Lond); 2002 Mar; 16(2):140-5. PubMed ID: 11988813
[TBL] [Abstract][Full Text] [Related]
13. Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.
García-Fiñana M; Hughes DM; Cheyne CP; Broadbent DM; Wang A; Komárek A; Stratton IM; Mobayen-Rahni M; Alshukri A; Vora JP; Harding SP
Diabetes Obes Metab; 2019 Mar; 21(3):560-568. PubMed ID: 30284381
[TBL] [Abstract][Full Text] [Related]
14. Screening for diabetic retinopathy: new perspectives and challenges.
Vujosevic S; Aldington SJ; Silva P; Hernández C; Scanlon P; Peto T; Simó R
Lancet Diabetes Endocrinol; 2020 Apr; 8(4):337-347. PubMed ID: 32113513
[TBL] [Abstract][Full Text] [Related]
15. Sight-threatening diabetic retinopathy at presentation to screening services in Fiji.
Damato EM; Murray N; Szetu J; Sikivou BT; Emma S; McGhee CN
Ophthalmic Epidemiol; 2014 Oct; 21(5):318-26. PubMed ID: 25157913
[TBL] [Abstract][Full Text] [Related]
16. Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance.
Kashim RM; Newton P; Ojo O
Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29351207
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a local optometric diabetic retinopathy screening service.
Warburton TJ; Hale PJ; Dewhurst JA
Diabet Med; 2004 Jun; 21(6):632-5. PubMed ID: 15154953
[TBL] [Abstract][Full Text] [Related]
18. 'I don`t need an eye check-up'. A qualitative study using a behavioural model to understand treatment-seeking behaviour of patients with sight threatening diabetic retinopathy (STDR) in India.
Kumar S; Mohanraj R; Raman R; Kumar G; Luvies S; Machhi SS; Chakrabarty S; Surya J; Ramakrishnan R; Conroy D; Sivaprasad S
PLoS One; 2023; 18(6):e0270562. PubMed ID: 37319187
[TBL] [Abstract][Full Text] [Related]
19. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
